EMERYVILLE, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary ...
Life Edit to receive upfront cash payment, research, and preclinical funding, and is eligible to receive milestone payments with tiered royalties on global net product sales CAMBRIDGE, MA and DURHAM, ...
WALTHAM, Mass. & DURHAM, N.C.--(BUSINESS WIRE)--Life Edit ® Therapeutics Inc., an ElevateBio ® company focused on next-generation gene editing technologies and therapeutics, today announced the ...
One of Moderna's New Year's resolutions appears to have been to expand its genomics output. The latest move in this area sees the mRNA company pen a partnership with ElevateBio’s Life Edit ...
Novo Nordisk (NVO) has partnered with U.S.-based biotech Life Edit Therapeutics to discover and develop gene editing treatments targeted at rare and cardiometabolic diseases, the companies announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback